Agitation associated with Alzheimer disease
- First identify pain, delirium + unmet needs
- Non-drug behavioral/environmental measures first
- Severe persistent agitation → drug may be needed
- Brexpiprazole is FDA-approved for this use
- Antipsychotics carry mortality/stroke warnings
- Use lowest effective dose; reassess frequently
- Do not medicate simple wandering alone
Use at a glance
- First identify pain, delirium + unmet needs
Treatment options
- Non-drug behavioral/environmental measures first
Practical pearls
- Brexpiprazole is FDA-approved for this use
Other treatment options
- Severe persistent agitation → drug may be needed
Monitoring / follow-up
- Antipsychotics carry mortality/stroke warnings
- Use lowest effective dose; reassess frequently
- Do not medicate simple wandering alone
Self-check
- What treatment approach is used in Agitation associated with Alzheimer disease?
lowest effective dose; reassess frequently.
- What should be done first in Agitation associated with Alzheimer disease?
identify pain, delirium + unmet needs.
Drugs used for this (1)
All clinical uses · Open the interactive console ↗